Baker Bros. Advisors as of Sept. 30, 2017
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 121 positions in its portfolio as reported in the September 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Incyte Corporation (INCY) | 32.4 | $4.0B | 34M | 116.74 | |
Seattle Genetics | 20.2 | $2.5B | 46M | 54.41 | |
Alexion Pharmaceuticals | 9.7 | $1.2B | 8.6M | 140.29 | |
ACADIA Pharmaceuticals (ACAD) | 7.9 | $973M | 26M | 37.67 | |
BioMarin Pharmaceutical (BMRN) | 4.5 | $550M | 5.9M | 93.07 | |
Genomic Health | 3.6 | $442M | 14M | 32.09 | |
Beigene | 3.3 | $403M | 3.9M | 103.46 | |
Dbv Technologies S A | 1.9 | $234M | 5.5M | 42.44 | |
Aquinox Pharmaceuticals | 1.3 | $155M | 11M | 14.19 | |
Advanced Accelerat spon ads each rep 2 ord | 1.2 | $152M | 2.2M | 67.62 | |
Spark Therapeutics | 1.0 | $123M | 1.4M | 89.16 | |
Ascendis Pharma A S (ASND) | 0.7 | $85M | 2.3M | 36.25 | |
Amarin Corporation (AMRN) | 0.6 | $79M | 23M | 3.50 | |
Avexis | 0.6 | $75M | 775k | 96.73 | |
BioCryst Pharmaceuticals (BCRX) | 0.6 | $73M | 14M | 5.24 | |
Invitae (NVTAQ) | 0.6 | $68M | 7.3M | 9.37 | |
Array BioPharma | 0.5 | $64M | 5.2M | 12.30 | |
Achaogen | 0.5 | $62M | 3.9M | 15.95 | |
Bellicum Pharma | 0.5 | $58M | 5.0M | 11.55 | |
Exelixis (EXEL) | 0.4 | $50M | 2.1M | 24.23 | |
Heron Therapeutics (HRTX) | 0.4 | $45M | 2.8M | 16.15 | |
Novavax Inc note 3.750% 2/0 | 0.3 | $40M | 89M | 0.45 | |
Neurocrine Biosciences (NBIX) | 0.3 | $38M | 617k | 61.28 | |
Bluebird Bio (BLUE) | 0.3 | $33M | 241k | 137.35 | |
Sangamo Biosciences (SGMO) | 0.3 | $32M | 2.1M | 15.00 | |
Acorda Therap note 1.75% 6/15 | 0.3 | $32M | 35M | 0.90 | |
Abeona Therapeutics | 0.2 | $29M | 1.7M | 17.05 | |
Halozyme Therapeutics (HALO) | 0.2 | $28M | 1.6M | 17.37 | |
Cerus Corporation (CERS) | 0.2 | $27M | 9.7M | 2.73 | |
Mirati Therapeutics | 0.2 | $27M | 2.3M | 11.70 | |
Galapagos Nv- (GLPG) | 0.2 | $26M | 260k | 101.75 | |
Intellia Therapeutics (NTLA) | 0.2 | $26M | 1.1M | 24.85 | |
Sage Therapeutics (SAGE) | 0.2 | $25M | 406k | 62.30 | |
Cymabay Therapeutics | 0.2 | $24M | 3.0M | 8.06 | |
Progenics Pharmaceuticals | 0.2 | $23M | 3.2M | 7.36 | |
Idera Pharmaceuticals | 0.2 | $23M | 10M | 2.23 | |
Merus N V (MRUS) | 0.2 | $23M | 1.2M | 19.87 | |
Insmed (INSM) | 0.2 | $22M | 700k | 31.21 | |
Neuroderm Ltd F | 0.2 | $22M | 572k | 38.90 | |
ImmunoGen | 0.2 | $21M | 2.7M | 7.65 | |
Xencor (XNCR) | 0.2 | $20M | 872k | 22.92 | |
Aimmune Therapeutics | 0.1 | $17M | 674k | 24.79 | |
Ignyta | 0.1 | $16M | 1.3M | 12.35 | |
Aerie Pharmaceuticals | 0.1 | $15M | 299k | 48.60 | |
Myokardia | 0.1 | $15M | 355k | 42.85 | |
Biomarin Pharma Inc convertible/ | 0.1 | $15M | 15M | 1.01 | |
Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.1 | $14M | 12M | 1.11 | |
Foamix Pharmaceuticals | 0.1 | $14M | 2.5M | 5.55 | |
Acorda Therapeutics | 0.1 | $12M | 520k | 23.65 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.1 | $13M | 5.1M | 2.52 | |
Ligand Pharmaceuticals In (LGND) | 0.1 | $10M | 73k | 136.16 | |
Newlink Genetics Corporation | 0.1 | $10M | 1.0M | 10.18 | |
Intra Cellular Therapies (ITCI) | 0.1 | $9.6M | 609k | 15.78 | |
Achillion Pharmaceuticals | 0.1 | $8.3M | 1.9M | 4.49 | |
Agios Pharmaceuticals (AGIO) | 0.1 | $8.6M | 129k | 66.75 | |
Loxo Oncology | 0.1 | $8.8M | 96k | 92.12 | |
Assembly Biosciences | 0.1 | $8.7M | 250k | 34.92 | |
Syros Pharmaceuticals | 0.1 | $8.5M | 575k | 14.72 | |
Vanda Pharmaceuticals (VNDA) | 0.1 | $7.6M | 424k | 17.90 | |
Alkermes (ALKS) | 0.1 | $7.6M | 150k | 50.84 | |
D Stemline Therapeutics | 0.1 | $7.0M | 634k | 11.10 | |
Gw Pharmaceuticals Plc ads | 0.1 | $7.6M | 75k | 101.49 | |
Glycomimetics (GLYC) | 0.1 | $7.9M | 563k | 13.99 | |
Contrafect | 0.1 | $7.9M | 7.2M | 1.11 | |
Aegerion Pharmaceuticals 2% Du cvbond | 0.1 | $7.6M | 9.5M | 0.80 | |
Dimension Therapeutics | 0.1 | $7.5M | 1.3M | 6.00 | |
Nabriva Therapeutics | 0.1 | $7.7M | 938k | 8.19 | |
Rigel Pharmaceuticals | 0.1 | $6.4M | 2.5M | 2.54 | |
Tetraphase Pharmaceuticals | 0.1 | $6.4M | 935k | 6.84 | |
Acceleron Pharma | 0.1 | $6.1M | 164k | 37.32 | |
Macrogenics (MGNX) | 0.1 | $6.7M | 364k | 18.48 | |
Aeglea Biotherapeutics | 0.1 | $5.6M | 1.1M | 4.93 | |
Spring Bk Pharmaceuticals In | 0.1 | $6.3M | 373k | 16.84 | |
Aevi Genomic | 0.1 | $5.7M | 4.5M | 1.26 | |
Epizyme | 0.0 | $4.4M | 233k | 19.05 | |
Array Biopharma Inc note 3.000% 6/0 | 0.0 | $5.4M | 3.0M | 1.80 | |
La Jolla Pharmaceuticl Com Par | 0.0 | $5.4M | 155k | 34.78 | |
Voyager Therapeutics (VYGR) | 0.0 | $4.9M | 237k | 20.59 | |
Selecta Biosciences | 0.0 | $5.3M | 290k | 18.25 | |
Versartis | 0.0 | $3.5M | 1.4M | 2.45 | |
Adamas Pharmaceuticals | 0.0 | $3.7M | 173k | 21.17 | |
Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.0 | $3.9M | 5.0M | 0.78 | |
Albireo Pharma | 0.0 | $4.2M | 200k | 20.95 | |
Tonix Pharmaceuticals Hldg C | 0.0 | $3.2M | 700k | 4.56 | |
Anaptysbio Inc Common (ANAB) | 0.0 | $3.9M | 111k | 34.95 | |
Clementia | 0.0 | $4.2M | 250k | 16.89 | |
Novavax | 0.0 | $2.3M | 2.0M | 1.14 | |
Karyopharm Therapeutics (KPTI) | 0.0 | $2.4M | 217k | 10.98 | |
Trevena | 0.0 | $2.4M | 950k | 2.55 | |
Protalix Biotherapeutics Inc note 4.500% 9/1 | 0.0 | $2.6M | 3.4M | 0.75 | |
Trillium Therapeutics, Inc. Cmn | 0.0 | $2.1M | 414k | 5.15 | |
Natera (NTRA) | 0.0 | $2.9M | 229k | 12.89 | |
Akari Therapeutics | 0.0 | $3.1M | 497k | 6.14 | |
Madrigal Pharmaceuticals (MDGL) | 0.0 | $2.6M | 58k | 44.98 | |
Ra Pharmaceuticals | 0.0 | $2.6M | 178k | 14.60 | |
Argenx Se (ARGX) | 0.0 | $2.3M | 100k | 22.61 | |
Ovid Therapeutics (OVID) | 0.0 | $2.9M | 333k | 8.57 | |
Krystal Biotech (KRYS) | 0.0 | $2.0M | 200k | 9.97 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $772k | 580k | 1.33 | |
BioDelivery Sciences International | 0.0 | $620k | 210k | 2.95 | |
Five Prime Therapeutics | 0.0 | $787k | 19k | 40.89 | |
Mediwound Ltd cmn | 0.0 | $1.2M | 226k | 5.35 | |
Immune Design | 0.0 | $1.5M | 149k | 10.35 | |
Affimed Therapeutics B V | 0.0 | $900k | 400k | 2.25 | |
Dynavax Technologies (DVAX) | 0.0 | $1.6M | 75k | 21.51 | |
Cellectis S A (CLLS) | 0.0 | $1.4M | 50k | 28.46 | |
Adaptimmune Therapeutics (ADAP) | 0.0 | $819k | 100k | 8.19 | |
Arbutus Biopharma (ABUS) | 0.0 | $1.1M | 181k | 6.20 | |
Ritter Pharmaceuticals | 0.0 | $980k | 2.8M | 0.35 | |
Sunesis Pharmaceuticals Inc Ne | 0.0 | $1.4M | 742k | 1.94 | |
Jounce Therapeutics | 0.0 | $1.6M | 100k | 15.58 | |
Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $98k | 13k | 7.39 | |
Chemocentryx | 0.0 | $364k | 49k | 7.42 | |
T2 Biosystems | 0.0 | $420k | 100k | 4.20 | |
Tenax Therapeutics | 0.0 | $125k | 348k | 0.36 | |
Proteon Therapeutics | 0.0 | $597k | 299k | 2.00 | |
Biotime Inc wts oct 1 18 | 0.0 | $4.0k | 20k | 0.20 | |
Biopharmx | 0.0 | $174k | 599k | 0.29 | |
Invivo Therapeutics Hldgs | 0.0 | $580k | 400k | 1.45 | |
Fulgent Genetics (FLGT) | 0.0 | $599k | 125k | 4.79 | |
Molecular Templates | 0.0 | $505k | 72k | 6.97 |